TP53 and breast cancer: In comparison to the mammary tumors in the wildtype p53 background, FSF-KrasG12D-induced cancers with the p53R172H mutant allele were mostly comprised of mesenchymal-like spindle cells, and fewer tumors were classified as poorly differentiated adenocarcinomas (Fig. 5C).